Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNMC.L Regulatory News (NMC)

  • There is currently no data for NMC

Statement re Possible Offer

9 Oct 2015 14:18

RNS Number : 8442B
Al Noor Hospitals Group PLC
09 October 2015
 



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

 

THIS ANNOUNCEMENT IS NOT AN ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE") AND THERE CAN BE NO CERTAINTY THAT AN OFFER WILL BE MADE, NOR AS TO THE TERMS ON WHICH ANY OFFER WILL BE MADE

 

FOR IMMEDIATE RELEASE

October 9th, 2015

 

The Board of Al Noor Hospitals Group Plc (the "Company") notes the recent media speculation in relation to the Company and confirms that it has received an approach from NMC Health Plc ("NMC") regarding a possible offer.

 

In accordance with Rule 2.6(a) of the Code, NMC is required, by not later than 5.00 p.m. on November 6th, 2015, to either announce a firm intention to make an offer for the Company in accordance with Rule 2.7 of the Code or announce that it does not intend to make an offer, in which case the announcement will be treated as a statement to which Rule 2.8 of the Code applies. This deadline can be extended with the consent of the Panel in accordance with Rule 2.6(c) of the Code.

 

A copy of this announcement will be available at www.alnoorhospital.com/investors.

 

The content of the website referred to in this announcement is not incorporated into and does not form part of this announcement.

 

Enquiries

Rothschild (lead financial adviser and co-sponsor)

Robert LeitãoHedley Goldberg

 

Tel: +44 207 280 5000

Goldman Sachs International (co-financial adviser and corporate broker)

Ben ThorpeNimesh Khiroya

 

Tel: +44 207 774 1000

Jefferies (corporate broker and co-sponsor)

Paul Nicholls

Henry Elphick

 

 

Tel: +44 207 029 8000

This announcement has been issued by and is the sole responsibility of the Company.

N M Rothschild & Sons Limited ("Rothschild"), which is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority in the United Kingdom, is acting exclusively for the Company and no-one else in connection with the matters set out in this announcement and will not be responsible to anyone other than the Company for providing the protections afforded to clients of Rothschild or for providing advice in relation to the matters set out in this announcement.

Goldman Sachs International, which is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority in the United Kingdom, is acting for the Company and no-one else in connection with the matters set out in this announcement and will not be responsible to anyone other than the Company for providing the protections afforded to clients of Goldman Sachs International nor for providing advice in relation to the matters in this announcement. Neither Goldman Sachs International nor any of its subsidiaries, branches or affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Goldman Sachs International in connection with this announcement, any statement contained herein or otherwise.

Jefferies International Limited ("Jefferies"), which is authorised and regulated by the Financial Conduct Authority in the United Kingdom, is acting exclusively for the Company and no-one else in connection with the matters set out in this announcement and will not be responsible to anyone other than the Company for providing the protections afforded to clients of Jefferies or for providing advice in relation to the matters set out in this announcement. The information contained in this announcement is not for release, publication or distribution to persons in any jurisdiction where to do so would breach any applicable law.

 

Disclosure requirements of the Code

 

Under Rule 8.3(a) of the Code, any person who is interested in 1% or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified. An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3.30 pm (London time) on the 10th business day following the commencement of the offer period and, if appropriate, by no later than 3.30 pm (London time) on the 10th business day following the announcement in which any securities exchange offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a securities exchange offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

 

Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1% or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror, save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 pm (London time) on the business day following the date of the relevant dealing.

 

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

 

Opening Position Disclosures must also be made by the offeree company and by any offeror

and Dealing Disclosures must also be made by the offeree company, by any offeror and by

any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4).

 

Details of the offeree and offeror companies in respect of whose relevant securities Opening

Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure

Table on the Takeover Panel's website at www.thetakeoverpanel.org.uk, including details of

the number of relevant securities in issue, when the offer period commenced and when any

offeror was first identified. You should contact the Panel's Market Surveillance Unit on +44

(0)20 7638 0129 if you are in any doubt as to whether you are required to make an Opening

Position Disclosure or a Dealing Disclosure.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
OFDLLFLVISLAIIE
Date   Source Headline
19th Mar 20184:01 pmRNSSale of Shares
19th Mar 20183:55 pmRNSExercise of share options
15th Mar 20184:56 pmRNSAmendment: Exercise of Options and Sale of Shares
15th Mar 20184:24 pmRNSGrant of Options
9th Mar 201811:02 amRNSGrant of Options
9th Mar 201811:02 amRNSGrant of Options
7th Mar 20187:00 amRNSFinal Results
28th Feb 201812:36 pmRNSNotice of Results
8th Feb 20189:08 amRNSDirector/PDMR Shareholding
6th Feb 20183:13 pmRNSDirector/PDMR Shareholding
2nd Feb 20187:00 amRNSAppointment of Joint Corporate Broker
29th Jan 20187:00 amRNSCompletion of Fakih IVF acquisition
22nd Jan 20187:00 amRNSEarnings accretive acquisitions in the UAE and KSA
4th Jan 20187:00 amRNSAcquisitions of outstanding minority interests
20th Dec 20177:00 amRNSGroup Strategy & Trading Update
11th Dec 20171:42 pmRNSDirector/PDMR Shareholding
1st Dec 20171:46 pmRNSDirector/PDMR Shareholding
30th Nov 20171:39 pmRNSTotal Voting Rights
28th Nov 20174:25 pmRNSDirector/PDMR Shareholding
24th Nov 20171:26 pmRNSPDMR Notification
17th Nov 20172:09 pmRNSDirector/PDMR Shareholding
17th Nov 20172:00 pmRNSExercise of share options
26th Oct 20171:28 pmRNSShare Plans Block Listing Application
13th Oct 20179:46 amRNSPDMR notification
25th Sep 20178:00 amRNSSignificant Expansion into Kingdom of Saudi Arabia
22nd Sep 20171:47 pmRNSDirector/PDMR Shareholding
19th Sep 20171:24 pmRNSHolding(s) in Company
14th Sep 20179:11 amRNSHolding(s) in Company
8th Sep 20174:22 pmRNSDirector/PDMR Shareholding
7th Sep 20173:40 pmRNSDirector/PDMR Shareholding
23rd Aug 20177:15 amRNSNew O&M Contract
23rd Aug 20177:00 amRNSHalf-year Report
22nd Aug 20172:37 pmRNSHolding(s) in Company
18th Aug 20177:00 amRNSNotice of Results
20th Jul 20172:40 pmRNSPDMR Notification
11th Jul 20172:18 pmRNSHolding(s) in Company
29th Jun 20177:02 amRNSNMC Health Board Changes
29th Jun 20177:00 amRNSTransfer of shareholding between concert parties
12th Jun 201711:00 amRNSDirector/PDMR Shareholding
9th Jun 20172:30 pmRNSDirector/PDMR Shareholding
23rd May 20174:08 pmRNSResults of Voting at AGM
18th May 20174:43 pmRNSDirector/PDMR Shareholding
9th May 20174:39 pmRNSDirector/PDMR Shareholding
2nd May 20177:00 amRNSAbu Dhabi regulatory and trading update
24th Apr 20173:38 pmRNSNMC Health AGM and Dividend Timetable
24th Mar 201710:25 amRNSNMC Completion of Acquisition of Al Zahra Hospital
8th Mar 20178:00 amRNSNMC Health promotes Prasanth Manghat to CEO
8th Mar 20177:00 amRNSNMC Final FY 2016 Results
2nd Mar 201711:56 amRNSUPDATE ON PROPOSED ACQUISITION OF AL ZAHRA
1st Mar 20177:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.